Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
at least try tell people why
cant sell on any platform
worthless share worth zilch
paid for comments
still worth 40p
baseless commentary
stop ramping
those crazy prices are if it gets to Phased 3 trials
stop ramping
What potential price range here on MS success ? Likely a partnership with major pharma? Could be $40 to $50 on MS + Alzheimers?
Had not occurred this MS trial would be a lot further down the road maybe with hundreds of patients or maybe been bought out or partnered!
hi , is there a link to a recording anyone could share on here please ?
Unprecedented was the word used by Larry Steinmam the guru on MS Expert.
Basically the MS trial is an unbelievable never seen before success.
The microgrial fug in the brain has cleared 50% in 6 months and still receding. Second patient is following the same as first. A 7 week gap in dosing in first patient showed no stop in fug reduction but a bit slower,
second patient won’t get 7 week gap in dosing.
All experts are very excited with results. Howard Wiener stated a trial in Alzheimer’s will be starting ‘shortly’ next.
Fug is my word for the stuff shown by PET scan in brain.
They are excited to see the next update ‘shortly’ on 9months dosing the first patient and 3months dosing on the second.
All in all a very exciting time !!
Mind blowing webinar. Can’t wait for the film HOLLYWOOD is making about H Wiener’s book which features all this about Tiziana , Howard said they are doing it now to include all data from this trial!!!!!
Thank you for the update MRK2020.
2 days trading above $1, can we make the 10 consecutive days requirement on the first attempt?
BB
@MRK2020
Excellent synopsis !
Many thanks
StarKnight
So UK clocks change to BST on 27th March 2022 in which case on 28th March USA markets close at 9 pm UK time
It is nic e to see some movement as been static far too long !
Good Luck All
StarKnight
I was listening while working. It was led by Howard Weiner. A few different clinicians came on to summarize data from the first MS patient. The indications were all positive, and above expectations. And well tolerated etc. The patient had a six week pause from drugs and they noted a decline in this period. They have now initiated a second patient as of January. Weiner noted some positive effects were reported by his doctor already. So, they were very bullish on data thus far. They plan to seek permission for other patients over next year. Outcomes to be reported for both patients in fall or earlier if available. Trial to follow .. likely up to 100 patients. Alzheimer's and ALS...I think are the other conditions they want to target...but that's way off.
So, in summary, it was a positive update re the data from one patient. So caveats apply. Rightly or wrongly It was not shareholder focussed, but clinical focussed.
Hi All
I have just been caught out trying to trade thinking US markets close at 9pm UK time which they normally do . They have jumped 1 hour ahead for their summer time as of 13 Mar 2022 - Daylight Saving Time Started so untill we change to British Summer time US markey closes at 8 pm UK time
https://www.timeanddate.com/time/change/usa/new-york
StarKnight
CREST is UK stocks only isn't it, so I'm not sure they'd have much to comment on...?
There is a contact form on the Accustem website and this email on Tils info@tizianalifesciences.com but I guess you've tried them?
Might be mad but bought some more !!
Hi Bluebelly
I didn't get chance was it of any benefit ? any highlights worth noting ? Is it worth watching or just the same old information repeated and re hashed ?
StarKnight
It was an hour long.
BB
Has anyone has a response from Philadelphia Stock Transfer agency ? as CREST holders we are waiting for a statement for the new Accustem line. If anyone has an contact email address it would be much appreciated. I have tried over 20 times to get a response from TILS or Accustem with not one reply.
Business update from Precision Bio.
https://investor.precisionbiosciences.com/node/9126/pdf
Anybody got any idea when my shares will kick into life in my Interactive account.
Yes Bo, correct, 40p.
Current price is closer to 40p equivalent uk??…